Compare TNGX & CSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TNGX | CSW |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | United States |
| Employees | N/A | 2600 |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.9B |
| IPO Year | 2020 | N/A |
| Metric | TNGX | CSW |
|---|---|---|
| Price | $27.08 | $291.36 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 5 |
| Target Price | $21.78 | ★ $323.20 |
| AVG Volume (30 Days) | ★ 2.7M | 137.8K |
| Earning Date | 05-08-2026 | 05-21-2026 |
| Dividend Yield | N/A | ★ 0.38% |
| EPS Growth | ★ 26.89 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $62,384,000.00 | N/A |
| Revenue This Year | N/A | $23.19 |
| Revenue Next Year | N/A | $19.04 |
| P/E Ratio | ★ N/A | $40.25 |
| Revenue Growth | ★ 48.29 | N/A |
| 52 Week Low | $5.60 | $230.45 |
| 52 Week High | $34.39 | $337.02 |
| Indicator | TNGX | CSW |
|---|---|---|
| Relative Strength Index (RSI) | 44.84 | 56.23 |
| Support Level | $19.74 | $286.82 |
| Resistance Level | $28.41 | $291.68 |
| Average True Range (ATR) | 1.76 | 11.40 |
| MACD | -0.50 | 0.58 |
| Stochastic Oscillator | 10.98 | 57.85 |
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
CSW Industrials Inc is a diversified industrial growth company with well-established, scalable platforms & domain expertise across three segments: Contractor Solutions, Engineered Building Solutions, & Specialized Reliability Solutions. The company's Contractor Solutions segment involves manufacturing efficient & performance-enhancing products for residential & commercial HVAC/R & plumbing applications, which are designed for professional end-use customers. The majority of the company's revenue is generated from the Contractor Solutions segment in the U.S. markets. products include mechanical products for heating, ventilation, air conditioning, & refrigeration, plumbing products, grilles, registers, & diffusers, building safety solutions, & high-performance specialty lubricants & sealants.